See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: May 31, 2005

Hereditary Angioedema Healthy Patient Studies Addictions

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Hereditary Angioedema

The purpose of this study is to show that C1-INH concentrate (an investigational product) shortens the time to onset of relief of symptoms of abdominal or facial HAE attacks, compared to placebo. You may participate in this study if you have a diagnosis of hereditary C1-INH deficiency, have a documented history of facial or abdominal attacks, and are age six years or older. Research site located in King of Prussia, Penn.

More Information

Please see http://www.centerwatch.com/patient/studies/cat653.html.

-----

Healthy Patient Studies

This is a DNA study for healthy Caucasians 18 or older with total cholesterol less than 200 mg/dl, glucose less than 126mg/dl, or blood pressure less than 140/90. Research site located in Pembroke Pines, Fla.

More Information

Please see http://www.centerwatch.com/patient/studies/phasei.html.

-----

Addictions

The purpose of this study is to test startle responses differences between people who gamble compulsively and those who do not. Participants will complete questionnaires about their gambling behaviors, provide a drug use and psychiatric history, and be assessed for startle response to environmental noise. Research site located in Los Angeles, Calif.

More Information

Please see http://www.centerwatch.com/patient/studies/cat219.html.

-----

Copyright 2005 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.